CS logo
small CS logo
Accelerated Enrollment Solutions (AES)

Phoenix, Arizona, United States

About Accelerated Enrollment Solutions (AES)


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Valneva Austria GmbH
2
Total Rows: 1

Clinical Trials at Accelerated Enrollment Solutions (AES)


During the past decade, Accelerated Enrollment Solutions (AES) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11110000Started TrialsCompleted Trails2020202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults
2020-09-17
2021-10-15
Completed
4,124
Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine Candidate (VLA1553)
2021-04-02
2025-12-01
Active, not recruiting
363

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsValneva Austria GmbH: 2Valneva Austria GmbH: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Accelerated Enrollment Solutions (AES)


According to Clinical.Site data, the most researched conditions in "Accelerated Enrollment Solutions (AES)" are "Chikungunya Virus Infection" (2 trials). Many other conditions were trialed in "Accelerated Enrollment Solutions (AES)" in a lesser frequency.

Clinical Trials Intervention Types at Accelerated Enrollment Solutions (AES)


Most popular intervention types in "Accelerated Enrollment Solutions (AES)" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "VLA1553" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Accelerated Enrollment Solutions (AES)


The vast majority of trials in "Accelerated Enrollment Solutions (AES)" are 2 trials for "All" genders.

Clinical Trials Status at Accelerated Enrollment Solutions (AES)


Currently, there are NaN active trials in "Accelerated Enrollment Solutions (AES)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Accelerated Enrollment Solutions (AES), undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Accelerated Enrollment Solutions (AES), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 1Active, not recruiting: 1Completed: 1Completed: 1